Quest Diagnostics

Quest Diagnostics

Prix: 203.06

Entreprise et modèle économique

Quest Diagnostics is a leading provider of diagnostic information services, primarily focused on laboratory testing and related services. Its core products include clinical laboratory tests, anatomic pathology services, and genetic testing. The company operates through various segments, including Diagnostic Information Services and Diagnostic Solutions, with major revenue sources stemming from patient testing, healthcare provider services, and employer services. Quest Diagnostics serves a diverse clientele, including hospitals, physicians, and patients.

Profil d’investissement

The investment profile of Quest Diagnostics is more aligned with dividend investors due to its consistent dividend yield of 2.0%. The company demonstrates stable revenue streams, although recent quarterly revenue showed a slight decline. This stability may appeal to those seeking income rather than aggressive growth. The stock may also attract value investors looking for established companies with reliable earnings.

Site officiel

Métriques fondamentales (expérimental)

BPA (TTM) — bénéfice par action des 12 derniers mois, $
9.17 OK
Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
3.2%
Surprise BPA
3.0% conforme
Volatilité 20 j
1.3% stable
Rendement du dividende
2.0% modéré dernière date ex-dividende: 2026-04-06
Données FMP / FinFeed mises à jour: 2026-06-13
Reco: Acheter Potentiel: 71 Risque: 36 Mis à jour: 2026-06-13 02:56
Comment fonctionne la recommandation
Pourquoi l’IA pense cela:
Strong fundamentals and positive momentum support growth potential.

Suivre dans le portefeuille

Graphique des prix

Recommandation IA Prévision d’analyste Événement calendrier Signal positif Signal négatif Neutre / mise à jour Conserver / informatif B My buy S My sell
Changements de recommandation IA
Date Avant Après Raison
2026-05-30 02:36 Conserver Acheter Stable earnings but mixed momentum signals present uncertainty.
2026-05-08 15:18 Conserver Weak momentum and fundamentals suggest caution.
2026-05-07 03:06 Conserver Acheter Компания показывает стабильные финансовые показатели, однако недавнее снижение цен акций и отрицательная динамика выручки могут указывать на неопределенность в краткосрочной перспективе.
Prévisions des analystes
Date Analyste Action Objectif Prix alors
2026-04-21 18:51 Evercore ISI Objectif relevé 210 → 225 205.18
2026-04-21 18:00 Jefferies Objectif relevé 220 → 225 205.18
2026-04-08 13:09 Evercore ISI Mettre à jour — → 210 198.81

Rien pour le moment